Verrica Pharmaceuticals Insider Trades
NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 12 · $18.18M
- Sales
- 0 · $0
- Shares bought / sold
- 4.28M / 0
- Net activity
- Net buying $18.2 million
Verrica Pharmaceuticals insider activity
Over the last 12 months, Verrica Pharmaceuticals insiders reported 13 transactions on SEC Form 4: 12 open-market purchases and 0 sales. Insiders bought $18.2 million and sold $0 worth of stock, for net insider buying of $18.2 million. The most recent filing shows Rosenberg Noah L. (CMO) buying 2,030 shares at $4.92 on Aug 18, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VRCA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VRCA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 18, 2026 | Kirby John J.Interim CFO | Buy | 5,000 | $24.65K | Form 4 |
| Aug 18, 2026 | Rosenberg Noah L.CMO | Buy | 2,030 | $9.99K | Form 4 |
| Aug 17, 2026 | Rosenberg Noah L.CMO | Buy | 4,200 | $20.62K | Form 4 |
| Aug 17, 2026 | Zawitz DavidChief Operating Officer | Buy | 6,000 | $29.88K | Form 4 |
| Aug 17, 2026 | Rieger JaysonCEO and President | Buy | 5,000 | $24.55K | Form 4 |
| Aug 14, 2026 | Rieger JaysonCEO and President | Buy | 20,000 | $101.20K | Form 4 |
| Dec 23, 2025 | Kirby John J.Interim CFO | Award | 10,000 | — | Form 4 |
| Nov 25, 2025 | Rieger JaysonCEO and President | Buy | 94,311 | $400.11K | Form 4 |
| Nov 25, 2025 | Zawitz DavidChief Operating Officer | Buy | 10,000 | $42.42K | Form 4 |
| Nov 25, 2025 | Kirby John J.Interim CFO | Buy | 3,536 | $15.00K | Form 4 |
| Nov 25, 2025 | Manning Paul BDirector | Buy | 2,750,762 | $11.67M | Form 4 |
| Nov 25, 2025 | Manning Paul BDirector | Buy | 1,375,380 | $5.84M | Form 4 |
| Nov 25, 2025 | Rosenberg Noah L.CMO | Buy | 2,357 | $10.00K | Form 4 |
| Mar 17, 2025 | Hayes Christopher G.CHIEF LEGAL OFFICER | Sale | 4,315 | $2.80K | Form 4 |
| Nov 26, 2024 | Rieger JaysonCEO and President | Gift | 50,000 | — | Form 4 |
| Nov 26, 2024 | Manning Paul BDirector | Gift | 450,000 | — | Form 4 |
| Nov 26, 2024 | Stalfort John A IIIDirector | Gift | 50,000 | — | Form 4 |
| Nov 22, 2024 | Rieger JaysonCEO and President | Buy | 280,898 | — | Form 4 |
| Nov 22, 2024 | Manning Paul BDirector | Buy | 4,494,382 | — | Form 4 |
| Nov 22, 2024 | Manning Paul BDirector | Buy | 18,426,966 | — | Form 4 |
| Nov 22, 2024 | Stalfort John A IIIDirector | Buy | 1,123,595 | — | Form 4 |
| Nov 6, 2024 | Kirby John J.Interim CFO | Award | 54,267 | — | Form 4 |
| Sep 19, 2024 | Manning Paul BDirector | Gift | 891,870 | — | Form 4 |
| Sep 19, 2024 | Manning Paul BDirector | Gift | 891,870 | — | Form 4 |
| Sep 19, 2024 | Manning Paul BDirector | Gift | 891,870 | — | Form 4 |
| Sep 19, 2024 | Manning Paul BDirector | Gift | 2,675,611 | — | Form 4 |
| Aug 27, 2024 | Goldenberg GaryChief Medical Officer | Sale | 3,601 | $8.86K | Form 4 |
| Aug 27, 2024 | Hayes Christopher G.CHIEF LEGAL OFFICER | Sale | 9,530 | $23.44K | Form 4 |
| Aug 26, 2024 | Goldenberg GaryChief Medical Officer | Sale | 9,888 | $26.30K | Form 4 |
| Aug 26, 2024 | Hayes Christopher G.CHIEF LEGAL OFFICER | Sale | 26,183 | $69.65K | Form 4 |
| Aug 24, 2023 | Bonaccorso JoeCHIEF COMMERCIAL OFFICER | Award | 125,000 | — | Form 4 |
| Aug 24, 2023 | Kohler TerryCHIEF FINANCIAL OFFICER | Award | 125,000 | — | Form 4 |
| Aug 24, 2023 | Hayes Christopher G.CHIEF LEGAL OFFICER | Award | 150,000 | — | Form 4 |
| Aug 24, 2023 | White TedPRESIDENT AND CEO | Award | 150,000 | — | Form 4 |
| Aug 24, 2023 | Goldenberg GaryChief Medical Officer | Award | 50,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4